(Q44090632)

29 November 2017

title

INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection (English)

1 reference

29 November 2017

Barry T Bloom

1

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

Expert Opinion on Investigational Drugs

29 November 2017

published in

1 reference

29 November 2017

volume

15

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

703-707

1 reference

MSCRAMM-mediated adherence of microorganisms to host tissues.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Effect of immunoglobulin therapy on phagocytosis by polymorphonuclear leucocytes in whole blood of neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.6.703

10.1517/13543784.15.6.703

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference